Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-11, Stock:ABBV, The news for the past five days is as follows:
2018-05-04: NEWS1: 3 Value Stocks for Income Investors.NEWS2: 3 Value Stocks for Income Investors.NEWS3: Pharma Stock Roundup: Mixed Q1 for MRK, PFE, FDA Nod for Kymriah&apos;s 2nd Indication.NEWS4: Is Gilead Sciences Stock Finally a Bargain?.NEWS5: Is Gilead Sciences Stock Finally a Bargain?.NEWS6: Is Gilead Sciences Stock Finally a Bargain?.NEWS7: Gilead Sciences, Inc. Stock Will Recover… Eventually.NEWS8: Gilead Sciences, Inc. Stock Will Recover… Eventually.
2018-05-07: NEWS1: How Amgen’s Enbrel and Neulasta Performed in 1Q18.NEWS2: Taltz: Therapy for Psoriasis Indication.NEWS3: Allergan’s US General Medicines Segment in 1Q18.
2018-05-08: NEWS1: Keytruda: Merck’s Immuno-Oncology Blockbuster Drug in 1Q18.NEWS2: Celgene’s Otezla Witnessed Solid Growth in 1Q18.NEWS3: Biogen’s Key Partnerships: Eisai, Pfizer, AbbVie, and Ionis.NEWS4: Why Did Biogen and AbbVie Recall Zinbryta?.NEWS5: AbbVie to Present at the UBS Global Healthcare Conference.NEWS6: How Analysts View Allergan after Its 1Q18 Earnings.
2018-05-09: NEWS1: How Did Regeneron Pharmaceuticals Perform in 1Q18?.NEWS2: 3 Top Biotech Stocks to Buy in May.
2018-05-10: NEWS1: 3 Dividend Stocks for In-the-Know Investors.NEWS2: Exploring AbbVie’s Cash Flows.NEWS3: What’s AbbVie’s Business Strategy for 2018?.NEWS4: Analyzing AbbVie’s Financial Performance.NEWS5: Exploring AbbVie’s Research Programs in Oncology and Neurology.NEWS6: Exploring the Key Aspects of AbbVie’s Research Pipeline.NEWS7: Analyzing AbbVie’s Humira, Imbruvica, and HCV Products.NEWS8: Analyzing AbbVie’s Product Performance.NEWS9: How Much Upside Do Analysts Expect from AbbVie?.NEWS10: Analysts’ Recommendations for Regeneron Pharmaceuticals in May.

Answer: Rise